|
Insider Trading: Vertex Pharmaceuticals Inc / Ma
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Vertex Pharmaceuticals Inc / Ma in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of Vertex Pharmaceuticals Inc / Ma since year 2005. Table 2 shows the detailed insider transactions of Vertex Pharmaceuticals Inc / Ma since 2005.
The reporting company's ticker symbol is VRTX.
The reporting company's CIK number is 875320.
The total value of stock buying since 2005 is $3,261,545.
The total value of stock sales is $73,359,535.
The total value of stock exercises is $26,487,186.
1 year stock price chart,
1 day stock price chart
VRTX 1 year chart VRTX 1 day chart
Figure 1. Monthly insider transaction values at Vertex Pharmaceuticals Inc / Ma (VRTX) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
03 04 05 06 07 08 09 10 11 12 01 2009 02 03 04 05 06 07 08 09 10 11 12 01 2010 02 -
Figure 2. Average prices of insider buys, sales, and option exercises at Vertex Pharmaceuticals Inc / Ma (VRTX) in the past 24 months. See table 2 for insider transaction details.
03 04 05 06 07 08 09 10 11 12 01 2009 02 03 04 05 06 07 08 09 10 11 12 01 2010 02 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for Vertex Pharmaceuticals Inc / Ma (VRTX).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2010-02 | 6,500 | 250,510 | 7,444 | 292,758 | 1,600 | 16,656 |
| 2010-01 | 0 | 0 | 4,209 | 167,964 | 1,600 | 16,656 |
| 2009-12 | 0 | 0 | 1,600 | 63,391 | 1,600 | 16,656 |
| 2009-11 | 0 | 0 | 27,168 | 1,071,077 | 25,574 | 335,275 |
| 2009-10 | 0 | 0 | 27,100 | 910,482 | 25,600 | 335,616 |
| 2009-09 | 0 | 0 | 32,000 | 1,189,024 | 32,000 | 419,520 |
| 2009-08 | 0 | 0 | 47,513 | 1,706,972 | 46,444 | 709,870 |
| 2009-07 | 0 | 0 | 58,291 | 2,027,785 | 54,298 | 750,001 |
| 2009-06 | 0 | 0 | 150,801 | 5,248,804 | 148,801 | 2,023,141 |
| 2009-05 | 0 | 0 | 149,005 | 4,333,132 | 12,400 | 123,754 |
| 2009-04 | 0 | 0 | 15,400 | 428,101 | 12,400 | 123,756 |
| 2009-03 | 0 | 0 | 3,650 | 104,823 | 2,400 | 23,256 |
| 2009-02 | 0 | 0 | 47,830 | 1,663,911 | 43,612 | 535,356 |
| 2009-01 | 0 | 0 | 29,900 | 978,612 | 29,900 | 328,530 |
| 2008-12 | 0 | 0 | 18,875 | 455,469 | 14,400 | 185,328 |
| 2008-11 | 0 | 0 | 70,890 | 1,863,351 | 54,400 | 730,528 |
| 2008-10 | 0 | 0 | 54,508 | 1,349,926 | 45,653 | 611,306 |
| 2008-09 | 0 | 0 | 40,804 | 1,072,251 | 40,804 | 413,103 |
| 2008-08 | 0 | 0 | 62,824 | 1,784,216 | 62,824 | 640,176 |
| 2008-07 | 0 | 0 | 99,161 | 3,427,295 | 96,236 | 1,457,777 |
| 2008-06 | 0 | 0 | 3,549 | 110,196 | 8,281 | 130,301 |
| 2008-05 | 0 | 0 | 34,451 | 938,072 | 20,000 | 283,996 |
| 2008-02 | 83,710 | 1,525,569 | 0 | 0 | 12,735 | 200,385 |
| 2008-01 | 0 | 0 | 0 | 0 | 40,000 | 463,200 |
| 2007-12 | 0 | 0 | 53,175 | 1,350,554 | 52,686 | 720,217 |
| 2007-11 | 4,990 | 125,016 | 140,899 | 3,531,318 | 140,000 | 1,913,800 |
| 2007-10 | 0 | 0 | 625 | 21,742 | 625 | 8,190 |
| 2007-09 | 0 | 0 | 91,550 | 3,661,655 | 91,550 | 2,390,426 |
| 2007-08 | 0 | 0 | 31,220 | 1,093,245 | 31,220 | 397,464 |
| 2007-07 | 0 | 0 | 1,125 | 34,247 | 1,125 | 13,828 |
| 2007-06 | 50,000 | 1,322,500 | 3,000 | 88,530 | 24,105 | 294,980 |
| 2007-05 | 0 | 0 | 115,878 | 3,547,710 | 39,864 | 572,267 |
| 2007-04 | 0 | 0 | 25,925 | 813,261 | 25,625 | 363,905 |
| 2007-03 | 0 | 0 | 15,273 | 434,519 | 14,950 | 143,113 |
| 2007-02 | 0 | 0 | 41,300 | 1,358,011 | 41,000 | 590,348 |
| 2007-01 | 0 | 0 | 11,425 | 420,406 | 11,125 | 143,845 |
| 2006-12 | 0 | 0 | 88,054 | 3,525,963 | 83,144 | 1,162,528 |
| 2006-11 | 0 | 0 | 86,274 | 3,808,439 | 52,686 | 840,477 |
| 2006-10 | 0 | 0 | 46,370 | 1,686,545 | 46,070 | 742,612 |
| 2006-09 | 0 | 0 | 23,500 | 808,095 | 23,500 | 370,025 |
| 2006-08 | 0 | 0 | 107,500 | 3,488,828 | 94,500 | 1,170,245 |
| 2006-07 | 0 | 0 | 63,460 | 2,251,011 | 63,460 | 813,041 |
| 2006-06 | 0 | 0 | 41,880 | 1,408,346 | 41,880 | 475,252 |
| 2006-05 | 455 | 14,550 | 49,416 | 1,698,660 | 46,500 | 542,886 |
| 2006-04 | 0 | 0 | 37,820 | 1,373,664 | 37,820 | 412,747 |
| 2006-03 | 650 | 23,400 | 50,441 | 2,088,486 | 45,308 | 530,571 |
| 2006-02 | 0 | 0 | 49,118 | 1,778,206 | 42,806 | 537,689 |
| 2006-01 | 0 | 0 | 30,645 | 1,029,048 | 29,432 | 462,587 |
| 2005-12 | 0 | 0 | 30,938 | 856,200 | 0 | 0 |
| 2005-11 | 0 | 0 | 600 | 15,234 | 0 | 0 |
Go to page: 1
2
3
Table 2. Detailed insider stock purchases, sales, and option exercises
for Vertex Pharmaceuticals Inc / Ma (VRTX)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2010-02-16 | Mueller Peter (EVP, Global R&D, CSO) | Sale | 1,600 | 38.55 | 61,679 |
| 2010-02-16 | Mueller Peter (EVP, Global R&D, CSO) | Option Exercise | 1,600 | 10.41 | 16,656 |
| 2010-02-16 | Winger Dennis L (Director) | Purchase | 6,500 | 38.54 | 250,510 |
| 2010-02-11 | Cordes Eugene (Director) | Sale | 2,000 | 38.52 | 77,050 |
| 2010-02-03 | Mueller Peter (EVP, Global R&D, CSO) | Sale | 3,844 | 40.07 | 154,029 |
| 2010-01-26 | Kelly Lisa (SVP, Human Resources) | Sale | 583 | 39.48 | 23,016 |
| 2010-01-26 | Mueller Peter (EVP, Global R&D, CSO) | Sale | 2,026 | 39.39 | 79,804 |
| 2010-01-15 | Mueller Peter (EVP Global R&D, CSO) | Sale | 1,600 | 40.72 | 65,144 |
| 2010-01-15 | Mueller Peter (EVP Global R&D, CSO) | Option Exercise | 1,600 | 10.41 | 16,656 |
| 2009-12-04 | Mueller Peter (EVP Global R&D, CSO) | Sale | 1,600 | 39.62 | 63,391 |
| 2009-12-04 | Mueller Peter (EVP Global R&D, CSO) | Option Exercise | 1,600 | 10.41 | 16,656 |
| 2009-11-25 | Boger Joshua S (Director) | Sale | 6,374 | 39.43 | 251,326 |
| 2009-11-25 | Boger Joshua S (Director) | Option Exercise | 6,374 | 13.11 | 83,563 |
| 2009-11-18 | Silva Paul M (V.P. and Corporate Controller) | Sale | 719 | 39.70 | 28,544 |
| 2009-11-18 | Boger Joshua S (Director) | Sale | 6,400 | 39.66 | 253,856 |
| 2009-11-18 | Boger Joshua S (Director) | Option Exercise | 6,400 | 13.11 | 83,904 |
| 2009-11-17 | Kelly Lisa (SVP, Human Resources) | Sale | 875 | 40.20 | 35,175 |
| 2009-11-11 | Boger Joshua S (Director) | Sale | 6,400 | 41.07 | 262,848 |
| 2009-11-11 | Boger Joshua S (Director) | Option Exercise | 6,400 | 13.11 | 83,904 |
| 2009-11-04 | Boger Joshua S (Director) | Sale | 6,400 | 37.40 | 239,328 |
| 2009-11-04 | Boger Joshua S (Director) | Option Exercise | 6,400 | 13.11 | 83,904 |
| 2009-10-27 | Boger Joshua S (Director) | Sale | 6,400 | 32.99 | 211,136 |
| 2009-10-27 | Boger Joshua S (Director) | Option Exercise | 6,400 | 13.11 | 83,904 |
| 2009-10-21 | Boger Joshua S (Director) | Sale | 6,400 | 33.17 | 212,288 |
| 2009-10-21 | Boger Joshua S (Director) | Option Exercise | 6,400 | 13.11 | 83,904 |
| 2009-10-19 | Graves Kurt (EVP, Chief Commercial Officer) | Sale | 1,500 | 34.70 | 52,050 |
| 2009-10-14 | Boger Joshua S (Director) | Sale | 6,400 | 34.20 | 218,880 |
| 2009-10-14 | Boger Joshua S (Director) | Option Exercise | 6,400 | 13.11 | 83,904 |
| 2009-10-07 | Boger Joshua S (Director) | Sale | 6,400 | 33.77 | 216,128 |
| 2009-10-07 | Boger Joshua S (Director) | Option Exercise | 6,400 | 13.11 | 83,904 |
| 2009-09-30 | Boger Joshua S (Director) | Sale | 6,400 | 37.82 | 242,048 |
| 2009-09-30 | Boger Joshua S (Director) | Option Exercise | 6,400 | 13.11 | 83,904 |
| 2009-09-23 | Boger Joshua S (Director) | Sale | 6,400 | 36.76 | 235,264 |
| 2009-09-23 | Boger Joshua S (Director) | Option Exercise | 6,400 | 13.11 | 83,904 |
| 2009-09-16 | Boger Joshua S (Director) | Sale | 6,400 | 36.83 | 235,712 |
| 2009-09-16 | Boger Joshua S (Director) | Option Exercise | 6,400 | 13.11 | 83,904 |
| 2009-09-09 | Boger Joshua S (Director) | Sale | 6,400 | 37.00 | 236,800 |
| 2009-09-09 | Boger Joshua S (Director) | Option Exercise | 6,400 | 13.11 | 83,904 |
| 2009-09-01 | Boger Joshua S (Director) | Sale | 6,400 | 37.38 | 239,200 |
| 2009-09-01 | Boger Joshua S (Director) | Option Exercise | 6,400 | 13.11 | 83,904 |
| 2009-08-25 | Boger Joshua S (Director) | Sale | 6,400 | 36.75 | 235,200 |
| 2009-08-25 | Boger Joshua S (Director) | Option Exercise | 6,400 | 13.11 | 83,904 |
| 2009-08-19 | Boger Joshua S (Director) | Sale | 6,400 | 35.57 | 227,648 |
| 2009-08-19 | Boger Joshua S (Director) | Option Exercise | 6,400 | 13.11 | 83,904 |
| 2009-08-14 | Silva Paul M (V.P. and Corporate Controller) | Sale | 750 | 33.99 | 25,492 |
| 2009-08-12 | Boger Joshua S (Director) | Sale | 6,400 | 34.19 | 218,816 |
| 2009-08-12 | Boger Joshua S (Director) | Option Exercise | 6,400 | 13.11 | 83,904 |
| 2009-08-05 | Boger Joshua S (Director) | Sale | 6,400 | 37.11 | 237,504 |
| 2009-08-05 | Boger Joshua S (Director) | Option Exercise | 6,400 | 13.11 | 83,904 |
| 2009-08-03 | Kelly Lisa (SVP, Human Resources) | Sale | 319 | 36.09 | 11,512 |
| 2009-08-03 | Boger Kenneth S (SVP & General Counsel) | Sale | 20,844 | 36.02 | 750,800 |
| 2009-08-03 | Boger Kenneth S (SVP & General Counsel) | Option Exercise | 20,844 | 17.96 | 374,254 |
| 2009-07-29 | Boger Joshua S (Director) | Sale | 6,400 | 36.36 | 232,704 |
| 2009-07-29 | Boger Joshua S (Director) | Option Exercise | 6,400 | 13.11 | 83,904 |
| 2009-07-28 | Boger Kenneth S (SVP & General Counsel) | Sale | 19,898 | 36.00 | 716,328 |
| 2009-07-28 | Boger Kenneth S (SVP & General Counsel) | Option Exercise | 19,898 | 15.44 | 307,225 |
| 2009-07-27 | Silva Paul M (V.P. and Corporate Controller) | Sale | 125 | 35.68 | 4,460 |
| 2009-07-22 | Boger Joshua S (Director) | Sale | 6,400 | 34.25 | 219,200 |
| 2009-07-22 | Boger Joshua S (Director) | Option Exercise | 6,400 | 13.11 | 83,904 |
| 2009-07-20 | Graves Kurt (EVP, Chief Commercial Officer) | Sale | 3,868 | 33.47 | 129,461 |
| 2009-07-15 | Mueller Peter (EVP Global R&D, CSO) | Sale | 2,400 | 32.88 | 78,912 |
| 2009-07-15 | Mueller Peter (EVP Global R&D, CSO) | Option Exercise | 2,400 | 9.69 | 23,256 |
| 2009-07-15 | Boger Joshua S (Director) | Sale | 6,400 | 32.92 | 210,688 |
| 2009-07-15 | Boger Joshua S (Director) | Option Exercise | 6,400 | 13.11 | 83,904 |
| 2009-07-09 | Boger Joshua S (Director) | Sale | 6,400 | 33.42 | 213,888 |
| 2009-07-09 | Boger Joshua S (Director) | Option Exercise | 6,400 | 13.11 | 83,904 |
| 2009-07-01 | Boger Joshua S (Director) | Sale | 6,400 | 34.71 | 222,144 |
| 2009-07-01 | Boger Joshua S (Director) | Option Exercise | 6,400 | 13.11 | 83,904 |
| 2009-06-26 | Boger Kenneth S (SVP & General Counsel) | Sale | 108,001 | 36.00 | 3,888,036 |
| 2009-06-26 | Boger Kenneth S (SVP & General Counsel) | Option Exercise | 108,001 | 13.86 | 1,496,461 |
| 2009-06-24 | Boger Joshua S (Director) | Sale | 6,400 | 33.90 | 216,960 |
| 2009-06-24 | Boger Joshua S (Director) | Option Exercise | 6,400 | 13.11 | 83,904 |
| 2009-06-17 | Boger Joshua S (Director) | Sale | 12,800 | 31.94 | 408,832 |
| 2009-06-17 | Boger Joshua S (Director) | Option Exercise | 12,800 | 13.11 | 167,808 |
| 2009-06-15 | Mueller Peter (EVP Global R&D, CSO) | Sale | 2,400 | 31.02 | 74,448 |
| 2009-06-15 | Mueller Peter (EVP Global R&D, CSO) | Option Exercise | 2,400 | 9.69 | 23,256 |
| 2009-06-12 | Cordes Eugene (Director) | Sale | 2,000 | 31.16 | 62,320 |
| 2009-06-10 | Boger Joshua S (Director) | Sale | 6,400 | 30.12 | 192,768 |
| 2009-06-10 | Boger Joshua S (Director) | Option Exercise | 6,400 | 13.11 | 83,904 |
| 2009-06-03 | Boger Joshua S (Director) | Sale | 6,400 | 31.41 | 201,024 |
| 2009-06-03 | Boger Joshua S (Director) | Option Exercise | 6,400 | 13.11 | 83,904 |
| 2009-05-27 | Boger Joshua S (Director) | Sale | 26,900 | 29.44 | 791,936 |
| 2009-05-26 | Boger Joshua S (Director) | Sale | 26,900 | 29.12 | 783,328 |
| 2009-05-18 | Silva Paul M (V.P. and Corporate Controller) | Sale | 468 | 28.44 | 13,309 |
| 2009-05-18 | Sachdev Amit (SVP, Corp Affairs & Pub Policy) | Sale | 783 | 28.44 | 22,268 |
| 2009-05-18 | Graves Kurt (EVP, Chief Commercial Officer) | Sale | 925 | 28.44 | 26,307 |
| 2009-05-18 | Garrison Richard C (SVP and Catalyst) | Sale | 532 | 28.45 | 15,135 |
| 2009-05-18 | Smith Ian F (EVP & CFO) | Sale | 925 | 28.44 | 26,307 |
| 2009-05-18 | Sanders Charles A (Director) | Sale | 3,333 | 28.44 | 94,790 |
| 2009-05-18 | Sanders Charles A (Director) | Option Exercise | 3,333 | 10.05 | 33,496 |
| 2009-05-15 | Mueller Peter (EVP Global R&D, CSO) | Sale | 2,400 | 28.56 | 68,544 |
| 2009-05-15 | Mueller Peter (EVP Global R&D, CSO) | Option Exercise | 2,400 | 9.69 | 23,256 |
| 2009-05-11 | Sanders Charles A (Director) | Sale | 3,333 | 30.41 | 101,356 |
| 2009-05-11 | Sanders Charles A (Director) | Option Exercise | 3,333 | 10.05 | 33,496 |
| 2009-05-07 | Mueller Peter (EVP, Global R&D, CSO) | Sale | 12,796 | 28.94 | 370,316 |
| 2009-05-07 | Smith Ian F (EVP & CFO) | Sale | 32,500 | 28.90 | 939,250 |
| 2009-05-07 | Boger Joshua S (CEO) | Sale | 22,050 | 28.95 | 638,347 |
| 2009-05-07 | Boger Kenneth S (SVP & General Counsel) | Sale | 11,826 | 28.89 | 341,653 |
| 2009-05-04 | Sanders Charles A (Director) | Sale | 3,334 | 30.08 | 100,286 |
| 2009-05-04 | Sanders Charles A (Director) | Option Exercise | 3,334 | 10.05 | 33,506 |
| 2009-04-28 | Graves Kurt (EVP, Chief Commercial Officer) | Sale | 2,507 | 32.00 | 80,224 |
| 2009-04-21 | Graves Kurt (EVP, Chief Commercial Officer) | Sale | 493 | 27.03 | 13,325 |
| 2009-04-15 | Mueller Peter (EVP Drug Innov.& Realiz, CSO) | Sale | 2,400 | 26.98 | 64,752 |
| 2009-04-15 | Mueller Peter (EVP Drug Innov.& Realiz, CSO) | Option Exercise | 2,400 | 9.69 | 23,256 |
| 2009-04-15 | Sachs Bruce I (Director) | Sale | 10,000 | 26.98 | 269,800 |
| 2009-04-15 | Sachs Bruce I (Director) | Option Exercise | 10,000 | 10.05 | 100,500 |
| 2009-03-19 | Lewis-hall Freda C (EVP, Medicines Development) | Sale | 1,250 | 29.11 | 36,387 |
| 2009-03-16 | Mueller Peter (EVP Drug Innov.& Realiz, CSO) | Sale | 2,400 | 28.52 | 68,436 |
| 2009-03-16 | Mueller Peter (EVP Drug Innov.& Realiz, CSO) | Option Exercise | 2,400 | 9.69 | 23,256 |
| 2009-02-17 | Mueller Peter (EVP Drug Innov.& Realiz, CSO) | Sale | 2,400 | 32.88 | 78,912 |
| 2009-02-17 | Mueller Peter (EVP Drug Innov.& Realiz, CSO) | Option Exercise | 2,400 | 9.69 | 23,256 |
| 2009-02-09 | Silva Paul M (V.P. and Corporate Controller) | Sale | 250 | 33.69 | 8,422 |
| 2009-02-06 | Smith Ian F (EVP & CFO) | Sale | 41,212 | 35.00 | 1,442,420 |
| 2009-02-06 | Smith Ian F (EVP & CFO) | Option Exercise | 41,212 | 12.43 | 512,100 |
| 2009-02-04 | Mueller Peter (EVP Drug Innov.& Realiz, CSO) | Sale | 1,118 | 33.81 | 37,799 |
| 2009-02-04 | Smith Ian F (EVP & CFO) | Sale | 2,850 | 33.81 | 96,358 |
| 2009-01-29 | Brandt Eric (Director) | Sale | 27,500 | 33.00 | 907,500 |
| 2009-01-29 | Brandt Eric (Director) | Option Exercise | 27,500 | 11.16 | 306,762 |
| 2009-01-15 | Mueller Peter (EVP Drug Innov.& Realiz, CSO) | Sale | 2,400 | 29.63 | 71,112 |
| 2009-01-15 | Mueller Peter (EVP Drug Innov.& Realiz, CSO) | Option Exercise | 2,400 | 9.07 | 21,768 |
| 2008-12-19 | Lewis-hall Freda C (EVP, Medicines Development) | Sale | 1,250 | 29.90 | 37,375 |
| 2008-12-15 | Garrison Richard C (SVP and Catalyst) | Sale | 1,975 | 25.02 | 49,414 |
| 2008-12-15 | Mueller Peter (EVP Drug Innov.& Realiz, CSO) | Sale | 2,400 | 25.81 | 61,944 |
| 2008-12-15 | Mueller Peter (EVP Drug Innov.& Realiz, CSO) | Option Exercise | 2,400 | 9.07 | 21,768 |
| 2008-12-11 | Lewis-hall Freda C (EVP, Medicines Development) | Sale | 1,098 | 26.00 | 28,548 |
| 2008-12-10 | Lewis-hall Freda C (EVP, Medicines Development) | Sale | 152 | 26.00 | 3,952 |
| 2008-12-03 | Boger Joshua S (President & CEO) | Sale | 12,000 | 22.85 | 274,236 |
| 2008-12-03 | Boger Joshua S (President & CEO) | Option Exercise | 12,000 | 13.63 | 163,560 |
| 2008-11-26 | Boger Joshua S (President & CEO) | Sale | 13,000 | 24.33 | 316,290 |
| 2008-11-26 | Boger Joshua S (President & CEO) | Option Exercise | 13,000 | 13.63 | 177,190 |
| 2008-11-19 | Boger Joshua S (President & CEO) | Sale | 13,000 | 25.46 | 330,980 |
| 2008-11-19 | Boger Joshua S (President & CEO) | Option Exercise | 13,000 | 13.63 | 177,190 |
| 2008-11-18 | Silva Paul M (V.P. and Corporate Controller) | Sale | 218 | 26.13 | 5,696 |
| 2008-11-18 | Sachdev Amit (SVP, Public Policy,Gov Affairs) | Sale | 791 | 26.20 | 20,724 |
| 2008-11-18 | Graves Kurt (EVP, Chief Commercial Officer) | Sale | 379 | 26.10 | 9,891 |
| 2008-11-18 | Garrison Richard C (SVP and Catalyst) | Sale | 86 | 26.12 | 2,246 |
| 2008-11-18 | Smith Ian F (EVP & CFO) | Sale | 16 | 26.18 | 418 |
| 2008-11-18 | Boger Kenneth S (SVP & General Counsel) | Sale | 15,000 | 26.69 | 400,350 |
| 2008-11-17 | Mueller Peter (EVP Drug Innov.& Realiz, CSO) | Sale | 2,400 | 27.14 | 65,136 |
| 2008-11-17 | Mueller Peter (EVP Drug Innov.& Realiz, CSO) | Option Exercise | 2,400 | 9.07 | 21,768 |
| 2008-11-12 | Boger Joshua S (President & CEO) | Sale | 13,000 | 26.77 | 348,010 |
| 2008-11-12 | Boger Joshua S (President & CEO) | Option Exercise | 13,000 | 13.63 | 177,190 |
| 2008-11-05 | Boger Joshua S (President & CEO) | Sale | 13,000 | 27.97 | 363,610 |
| 2008-11-05 | Boger Joshua S (President & CEO) | Option Exercise | 13,000 | 13.63 | 177,190 |
| 2008-10-29 | Boger Joshua S (President & CEO) | Sale | 13,000 | 21.96 | 285,480 |
| 2008-10-29 | Boger Joshua S (President & CEO) | Option Exercise | 13,000 | 13.63 | 177,190 |
| 2008-10-22 | Boger Joshua S (President & CEO) | Sale | 5,600 | 22.88 | 128,128 |
| 2008-10-22 | Boger Joshua S (President & CEO) | Option Exercise | 13,000 | 13.63 | 177,190 |
| 2008-10-21 | Graves Kurt (EVP, Chief Commercial Officer) | Sale | 970 | 25.65 | 24,880 |
| 2008-10-15 | Mueller Peter (EVP Drug Innov.& Realiz, CSO) | Sale | 2,400 | 26.77 | 64,248 |
Go to page: 1
2
3
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Vertex Pharmaceuticals Inc / Ma (symbol VRTX,
CIK number 875320) see
the Securities and Exchange Commission (SEC) website.
|
|
